Walleye Trading’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,246
Closed -$226K 5332
2021
Q3
$226K Buy
+3,246
New +$250K ﹤0.01% 3731
2021
Q1
Sell
-2,757
Closed -$153K 4785
2020
Q4
$153K Sell
2,757
-2,988
-52% -$129K ﹤0.01% 3695
2020
Q3
$229K Buy
+5,745
New +$244K ﹤0.01% 2906
2018
Q4
Sell
-1,392
Closed -$49K 4600
2018
Q3
$49K Buy
+1,392
New +$44.1K ﹤0.01% 4554

Other funds holding ATRC

Walleye Trading's ATRC Position: Q4 2021 in Review

Walleye Trading sold out of AtriCure (ATRC) in Q4 2021, closing a stake of 3,246 shares — an estimated $226K sold.

Walleye Trading first reported a position in ATRC in Q3 2018 and held it in 4 quarters. The position peaked at $229K in Q3 2020. 217 funds tracked by Wall St. Rank hold ATRC as of Q4 2021.

  • Walleye Trading reported no remaining AtriCure position as of Q4 2021 after selling out during the quarter.
  • Walleye Trading sold 3,246 AtriCure shares in Q4 2021, an estimated $226K.
  • Walleye Trading first reported a position in AtriCure in Q3 2018 and held it in 4 quarters.
  • Walleye Trading's AtriCure position peaked at $229K in Q3 2020.
  • 217 funds tracked by Wall St. Rank held AtriCure as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.